ArticleFrontiers in cellular and infection microbiology2025
Immune activation and mucin dysregulation in pediatric refractory
Article in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Early clinical predictors of macrolide-resistant Mycoplasma pneumoniae pneumonia in hospitalized children during the 2024 outbreak in South Korea.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026Article
- Obstructive fibrinous tracheal pseudomembrane complicated with bronchial mucus plug: A rare post-intubation complication case report.Journal of anesthesia and translational medicine · 2026Article
- Development of a nomogram to predict acute liver injury in children withFrontiers in pediatrics · 2026Article
- Effect of intravenous immunoglobulin combined with azithromycin sequential therapy on clinical outcomes and immune response in children withFrontiers in medicine · 2026Article
- Early prediction of plastic bronchitis in pediatric patients withFrontiers in cellular and infection microbiology · 2026Article
- Immune dysregulation inFrontiers in immunology · 2026Review
- A nursing perspective on bronchoscopic intervention strategies for children with macrolide-unresponsiveFrontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Children with refractory Methods: From January 2022 to December 2023, children meeting the criteria for RMPP and requiring bronchoscopy were enrolled, and BALF samples were collected for analysis. Patients were stratified according to the presence or absence of mucus plugs. Clinical features, serologic parameters, BALF cytokine profiles, macrolide-resistance mutations, and epithelial and mucin biomarkers were compared between groups. Correlations between systemic inflammatory markers and BALF markers were analyzed, followed by enrichment analyses of differentially expressed BALF markers. Finally, factors independently associated with mucus plug formation were identified. Results: Eighty-eight children with RMPP were enrolled, including 37 with mucus plugs and 51 without. The mucus plug group required more frequent bronchoscopy and exhibited lower lymphocyte, monocyte, platelet, total protein, albumin, sodium, and potassium levels. Conversely, C-reactive protein (CRP), procalcitonin (PCT), creatine kinase (CK), lactate dehydrogenase (LDH), and serum ferritin levels were markedly elevated. BALF analysis revealed significantly higher levels of interleukin (IL)-2, IL-4, IL-6, IL-12p70, IL-17, interferon-γ (IFN-γ), tumor necrosis factor-α (TNF-α), Krebs von den Lungen-6 (KL-6), surfactant protein A (SP-A), and MUC5B in the mucus plug group. Rates of macrolide-resistance mutations were comparable between groups. Serum LDH, CRP, and CK levels correlated positively with BALF pro-inflammatory cytokines (IL-6, IFN-γ, and TNF-α), whereas albumin and sodium levels showed inverse correlations with these cytokines and with epithelial injury markers (KL-6 and SP-A). Enrichment analyses indicated that differentially expressed cytokines and mucins were primarily involved in inflammation-related pathways and immune effector processes. In multivariable analysis, only serum total protein remained independently associated with mucus plug formation. Conclusions: Children with RMPP and mucus plugs exhibited higher BALF cytokine levels, elevated epithelial injury markers (KL-6 and SP-A), and relatively increased MUC5B expression. Lower serum total protein was independently associated with mucus plug formation. These findings refine the pathophysiological understanding of RMPP with mucus plugs and may inform targeted anti-inflammatory and mucus-modulating therapeutic strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.